Sign in

CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company

CUMBERLAND PHARMACEUTICALS INC

Sign in to watch
Ticker
CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TN
Entity type
operating
EIN
621765329
Phone
615-255-0068
Business address
1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
  1. 4 Grant or award Director acquired 1,000 shares (grant or award)
  2. 4 Grant or award Director acquired 1,000 shares (grant or award)
  3. 4 Grant or award Director acquired 5,000 shares (grant or award)
  4. 4 Grant or award Director acquired 1,000 shares (grant or award)
  5. 4 Grant or award Director acquired 1,000 shares (grant or award)
  6. 4 Grant or award Chief Financial Officer acquired 2,500 shares (grant or award)
  7. 4 Grant or award VP and Chief Compliance Office acquired 4,000 shares (grant or award)
  8. 4 Grant or award Sr VP/Chief Commercial Officer acquired 5,000 shares (grant or award)
  9. 4 Grant or award SVP and Chief Development Off. acquired 25,000 shares (grant or award)
  10. 4 Grant or award Chairman and CEO acquired 100,000 shares (grant or award)
  11. 4 Gift Chairman and CEO gave 40,000 shares (gift)
  12. 4 Open-market sale Director sold 1,000 shares at $4.79 ($4,790)
  13. 4 Shares withheld for taxes VP and Chief Compliance Office gave up 2,149 shares (to pay taxes)
  14. 4 Shares withheld for taxes Sr VP/Chief Commercial Officer gave up 472 shares (to pay taxes)
  15. 4 Shares withheld for taxes SVP and Chief Development Off. gave up 3,710 shares (to pay taxes)
  16. 4 Open-market buy Director bought 1,714 shares at an average $5.56 ($9,526)
  17. 4 Open-market buy Director bought 1,338 shares at an average $5.65 ($7,555)
  18. 4 Open-market buy Chairman and CEO bought 1,174 shares at an average $5.65 ($6,639)
  19. 4 Open-market buy Director bought 1,174 shares at an average $5.65 ($6,639)
  20. 4 Open-market sale Director sold 11,570 shares at an average $5.29 ($61,261)

Page 14 of 26 · 512 filings